Asymptomatic infection after BNT162b2 mRNA COVID-19 vaccination in multiple sclerosis patient

Acta Neurol Belg. 2022 Apr;122(2):565-566. doi: 10.1007/s13760-021-01799-8. Epub 2021 Sep 16.
No abstract available

Publication types

  • Letter

MeSH terms

  • Asymptomatic Infections
  • BNT162 Vaccine
  • COVID-19 Vaccines / adverse effects
  • COVID-19* / prevention & control
  • Humans
  • Multiple Sclerosis*
  • RNA, Messenger
  • Vaccination / adverse effects

Substances

  • COVID-19 Vaccines
  • RNA, Messenger
  • BNT162 Vaccine